Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:40 am Purchase |
2023-12-31 | 13G | Editas Medicine, Inc. EDIT |
Deep Track Capital, LP | 5,473,086 6.700% |
979,670 (+21.80%) |
Filing History |
| 2024-02-14 08:39 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-2,500,000 (-55.56%) |
Filing History |
| 2024-02-14 08:39 am Purchase |
2023-12-31 | 13G | Dynavax Technologies Corporation DVAX |
Deep Track Capital, LP | 7,093,214 5.490% |
537,034 (+8.19%) |
Filing History |
| 2024-02-14 08:37 am Purchase |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 3,490,506 9.250% |
671,461 (+23.82%) |
Filing History |
| 2024-02-14 08:37 am Sale |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 11,869,297 6.820% |
-3,130,703 (-20.87%) |
Filing History |
| 2024-02-14 08:36 am Sale |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 0 0.000% |
-1,816,531 (Position Closed) |
Filing History |
| 2024-02-14 08:35 am Sale |
2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 2,323,456 6.250% |
-700,000 (-23.15%) |
Filing History |
| 2024-02-14 08:35 am Purchase |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
Deep Track Capital, LP | 2,036,990 7.670% |
676,814 (+49.76%) |
Filing History |
| 2024-02-14 08:34 am Sale |
2023-12-31 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 2,510,736 2.870% |
-2,489,264 (-49.79%) |
Filing History |
| 2024-02-14 08:33 am Sale |
2023-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 0 0.000% |
-1,704,000 (Position Closed) |
Filing History |
| 2024-02-14 08:33 am Purchase |
2023-12-31 | 13G | Agenus Inc. AGEN |
Deep Track Capital, LP | 1,584,877 8.310% |
209,227 (+15.21%) |
Filing History |
| 2024-02-14 08:32 am Sale |
2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 0 0.000% |
-3,952,000 (Position Closed) |
Filing History |
| 2024-02-12 4:01 pm Purchase |
2024-02-02 | 13G | Invivyd, Inc. IVVD |
Deep Track Capital, LP | 9,000,000 7.560% |
9,000,000 (New Position) |
Filing History |
| 2024-01-26 4:20 pm Purchase |
2024-01-16 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 5,000,000 5.720% |
2,489,264 (+99.14%) |
Filing History |
| 2024-01-26 09:21 am Sale |
2023-12-31 | 13G | Allakos Inc. ALLK |
Deep Track Capital, LP | 2,510,736 2.870% |
-2,388,443 (-48.75%) |
Filing History |
| 2024-01-19 4:38 pm Purchase |
2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 4,500,000 5.550% |
2,500,000 (+125.00%) |
Filing History |
| 2024-01-19 09:08 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-684,200 (-25.49%) |
Filing History |
| 2023-12-22 4:04 pm Purchase |
2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL |
Deep Track Capital, LP | 9,230,769 8.380% |
9,230,769 (New Position) |
Filing History |
| 2023-11-02 4:09 pm Purchase |
2023-10-23 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.650% |
3,710,412 (New Position) |
Filing History |
| 2023-11-02 4:08 pm Purchase |
2023-10-23 | 13G | Aligos Therapeutics, Inc. ALGS |
Deep Track Capital, LP | 291,839 9.990% |
291,839 (New Position) |
Filing History |